SYT11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.335000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.631200E-01
Normal-vs-Stage2
9.285800E-01
Normal-vs-Stage3
2.190800E-01
Normal-vs-Stage4
7.114200E-01
Stage1-vs-Stage2
5.367200E-01
Stage1-vs-Stage3
2.358800E-01
Stage1-vs-Stage4
8.919400E-01
Stage2-vs-Stage3
6.295800E-01
Stage2-vs-Stage4
6.995400E-01
Stage3-vs-Stage4
2.203600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.370400E-01
Normal-vs-AfricanAmerican
4.469800E-01
Normal-vs-Asian
2.328800E-01
Caucasian-vs-AfricanAmerican
4.702000E-01
Caucasian-vs-Asian
2.392000E-02
AfricanAmerican-vs-Asian
3.100600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.253200E-01
Normal-vs-Female
9.382200E-01
Male-vs-Female
8.780200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.496200E-01
Normal-vs-Age(41-60Yrs)
8.449000E-01
Normal-vs-Age(61-80Yrs)
9.453200E-01
Normal-vs-Age(81-100Yrs)
5.588300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.571400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.442600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.451200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.357400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.363640E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.195800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.690600E-01
Normal-vs-Daily Drinker
1.125790E-01
Normal-vs-Weekly Drinker
4.855800E-01
Normal-vs-Occasional Drinker
3.359800E-01
Normal-vs-Social Drinker
9.735400E-01
Non Drinker-vs-Daily Drinker
3.536400E-01
Non Drinker-vs-Weekly Drinker
7.656200E-01
Non Drinker-vs-Occasional Drinker
2.569600E-01
Non Drinker-vs-Social Drinker
7.681000E-01
Daily Drinker-vs-Weekly Drinker
2.719400E-01
Daily Drinker-vs-Occasional Drinker
1.150640E-01
Daily Drinker-vs-Social Drinker
1.471590E-01
Weekly Drinker-vs-Occasional Drinker
1.874780E-01
Weekly Drinker-vs-Social Drinker
4.520200E-01
Occasional Drinker-vs-Social Drinker
3.282600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.682600E-01
Normal-vs-Grade 2
4.906600E-01
Normal-vs-Grade 3
2.333000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.635400E-01
Grade 1-vs-Grade 3
1.182550E-01
Grade 1-vs-Grade 4
4.682600E-01
Grade 2-vs-Grade 3
5.202200E-02
Grade 2-vs-Grade 4
4.906600E-01
Grade 3-vs-Grade 4
2.333000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.130600E-01
Normal-vs-NonDiabetic
8.866000E-01
Diabetic-vs-NonDiabetic
2.231400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.067800E-01
Normal-vs-NoPancreatitis
8.857200E-01
Pancreatitis-vs-NoPancreatitis
3.121600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.316950E-01
Normal-vs-N1
8.133600E-01
N0-vs-N1
2.935700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.133200E-01
Normal-vs-TP53-NonMutant
2.499400E-01
TP53-Mutant-vs-TP53-NonMutant
1.666170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
